From the Pakistan-India Border to Our Borderplex: A Doctor's Journey Dr. Muhammad Moiz Tahir tackles El Paso's health challenges with community-driven care
Texas Tech University Health Sciences Center El Paso
Researchers at Washington University in St. Louis can more effectively study mutations that cause heart disease by putting cells through their paces.
Researchers at The University of Texas MD Anderson Cancer Center have demonstrated that therapeutically restoring ‘youthful’ levels of a specific subunit of the telomerase enzyme can significantly reduce the signs and symptoms of aging in preclinical models. If these findings are confirmed in clinical studies, there may be therapeutic implications for age-related diseases such as Alzheimer’s, Parkinson’s, heart disease and cancer.
A team of international researchers has revealed a new, simple clinical test to detect Calcium Release Deficiency Syndrome (CRDS), a life-threatening genetic arrhythmia that causes dangerously fast heartbeats and can lead to severe complications such as sudden cardiac arrest and death.
Heart attacks have been the leading cause of death in the U.S. for a century. While most treatments for cardiac events target breaking down blood clots, Georgia Tech researchers have found a way to prevent blood clots from even forming. Dramatically, their drug is shown to completely knock out the formation of blood clots without increasing the risks of bleeds in vivo.
Cuando el electrofisiólogo el Dr. Eugenio Cingolani, no está atendiendo a pacientes, suele estar en su laboratorio, investigando tratamientos mejorados para los trastornos del ritmo cardiaco.
When electrophysiologist Eugenio Cingolani, MD, isn’t seeing patients, he can usually be found in his laboratory, investigating improved treatments for heart rhythm disorders.
Dr. Okajima's current research is focused on antiplatelet therapy, a cornerstone treatment for preventing heart attacks and strokes in patients with a history of coronary artery disease. By considering a person's genes, doctors may be able to cater better treatments, especially for Hispanic patients.
Now that weight loss drugs like Wegovy have been shown to reduce the risk of heart disease and treat sleep apnea, more men are likely to start taking them, according to an analysis by Reuters. ...
Everyone knows exhaustion is a rite of passage for new parents, which is why Henric Nieminen ignored the symptoms at first.
Using an advanced artificial intelligence tool, researchers at the Icahn School of Medicine at Mount Sinai have identified rare coding variants in 17 genes that shed light on the molecular basis of coronary artery disease (CAD), the leading cause of morbidity and mortality worldwide. The discoveries, detailed in the June 11 online issue of Nature Genetics, reveal genetic factors impacting heart disease that open new avenues for targeted treatments and personalized approaches to cardiovascular care. The investigators used an in silico, or computer-derived, score for coronary artery disease (ISCAD) that holistically represents CAD, as described in a previous paper by the team in The Lancet. The ISCAD score incorporates hundreds of different clinical features from the electronic health record, including vital signs, laboratory test results, medications, symptoms, and diagnoses. To build the score, they trained machine learning models on the electronic health records of 604,914 individuals
People from South Asian countries tend to develop heart disease 10 years earlier than other populations. Kevin Shah, MD, is working to change that.
President of Mount Sinai Fuster Heart Hospital given top honor for his scientific excellence and successful global education initiatives on cardiovascular disease
Exercising at a high level doesn’t affect the progression of calcium buildup in the arteries, even among older athletes such as marathoners who tend to have higher coronary artery calcium (CAC) scores, according to new research from UT Southwestern Medical Center. But a longer duration of exercise is associated with higher CAC.
Cleveland Clinic researchers found higher amounts of the sugar alcohol xylitol are associated with increased risk of cardiovascular events like heart attack and stroke.
New research from the University of Illinois Urbana-Champaign has linked multiple types of per- and polyfluoroalkyl substances (PFAS, also known as “forever chemicals”) with increased risk of cardiovascular diseases in postmenopausal women. Specifically, the study reveals how PFAS chemicals interact with pro-inflammatory pathways in older women, providing potential explanations for the increased risk.